In the years since those reviews were published, increased expression of SCD has been reported in an ever-growing list of cancer types including breast [57], colorectal [175], ovarian [176], endometrial [177], bladder [178], colorectal cancer [175], and clear-cell renal cell carcinoma [179]. This evidence concerns the gene SCD and colorectal cancer.